Stock Name: CAS
Amount: CAD 0.04
Announcement Date: 10/05/2012
Record Date: 23/05/2012
Dividend Detail:
KINGSEY FALLS, QC, May 10, 2012 /CNW Telbec/ - Cascades Inc. (TSX: CAS),
a leader in the recovery and manufacturing of green packaging and
tissue paper products, announces its financial results for the
three-month period ended March 31, 2012.
Q1-2012 Financial Highlights
Sales of $891 million
(compared to $913 million in Q4-2011 (-2%) and $774 million in Q1-2011
(+15%))
Excluding specific items
EBITDA of $72 million
(compared to $51 million in Q4-2011 (+41%) and $37 million in Q1-2011
(+95%))
Net earnings per share of $0.04
(compared to a net loss of $0.04 in Q4-2011 and net earnings of $0.01 in
Q1-2011)
Including specific items
EBITDA of $75 million
(compared to $37 million in Q4-2011 (+103%) and $30 million in Q1-2011
(+150%))
Net earnings per share of $0.06
(compared to net earnings of $0.05 in Q4-2011 and a net loss of $0.08 in
Q1-2011)
Net debt of $1,524 million (compared to $1,485 million as at December
31, 2011), including $173 million of non-recourse debt.
Strategic Initiatives
Acquisition of the corrugated boxes converting and warehousing
facilities of Bird Packaging Limited located in Ontario.
Announcement of investments of $30 million and closures of three plants
as part of the consolidation of our corrugated products sector in
Ontario.
Consolidation of our honeycomb packaging manufacturing operations with
the announced closure of Cascades Enviropac in Toronto.
Announcement of the closure of the Trenton containerboard mill effective
June 1, 2012 due to financial losses and unsatisfactory labor
relations.
Commenting on the first quarter results, Mr. Alain Lemaire, President
and Chief Executive Officer stated: "We announce today financial
results which are a significant improvement over the previous quarter
and the same period last year. This performance is below our
expectations due to a low level of productivity of our Containerboard
manufacturing operations. Our Tissue Papers Group continues to perform
well and our Specialty Products Group shows improved results. During
this past quarter, we benefited from lower recycled fibre costs and
average selling prices have held for most of our products despite
volatile demand. Continuing to implement our action plan, we have been
particularly active with restructuring and capital allocation measures
aimed at modernizing our operating units. The actions taken by our team
reflect our commitment to improve profitability and efficiency in an
increasingly competitive market."
Looking ahead in the near-term, Mr. Lemaire added: "The economic
environment remains difficult but seems to be gaining momentum in North
America which is encouraging as we enter what have been historically
our two strongest quarters of the year. We have identified and fixed
certain of our operational issues which should enable operations to
produce in line with usual standards. Moreover we are starting to see
the benefits of the measures we have taken to improve our portfolio of
assets, a good example being the Tissue Papers Group. In Europe, the
economic uncertainty poses unique challenges in the short term but we
believe we have the right platform to face this situation.
We will likely continue to face high variable costs and a strong
Canadian dollar. After a slight increase in the beginning of the year,
we expect the pricing environment for recycled fibre to be more
favorable during the next quarter."
Financial Summary
Selected consolidated information | �� | �� | �� | ||
(in millions of Canadian dollars, except amounts per share) (unaudited) | Q1/2012 | Q1/2011 | Q4/2011 | ||
�� | �� | �� | �� | ||
Sales | 891 | 774 | 913 | ||
Excluding specific items 1 | �� | �� | �� | ||
�� | Operating income before depreciation and amortization (OIBD or EBITDA) | 72 | 37 | 51 | |
�� | Operating income | 26 | 1 | - | |
�� | Net earnings (loss) | 4 | 1 | (4) | |
�� | �� | per common share | $0.04 | $0.01 | $(0.04) |
�� | Cash flow from continuing operations (adjusted) | 48 | 15 | 40 | |
As reported | �� | �� | �� | ||
�� | Operating income before depreciation and amortization (OIBD or EBITDA) | 75 | 30 | 37 | |
�� | Operating income (loss) | 29 | (6) | (14) | |
�� | Net earnings (loss) | 6 | (8) | 5 | |
�� | �� | per common share | $0.06 | $(0.08) | $0.05 |
�� | Cash flow from continuing operations (adjusted)�� | 48 | 15 | 35 |
Note 1 - see the supplemental information on non-IFRS measures.
Results analysis for the three-month period ended March 31, 2012
(compared to the previous year)
In comparison with the same period last year, sales rose by 15% to $891
million as of result of higher selling prices, the net contribution of
business acquisitions over divestitures and the full consolidation of
the results of Reno de Medici ("RdM") since Q2-2011 that more than
offset lower volumes.
The above-mentioned factors combined with lower raw material costs
resulted in operating income, excluding specific items, amounting to
$26 million compared to $1 million in Q1-2011. On a segmented basis,
our Containerboard sector posted similar profitability. Our Tissue
Papers and Specialty Products sectors surpassed 2011 first quarter's
results due to improved productivity and lower recycled fiber costs.
Our Boxboard sector in Europe benefited from the full consolidation
from RdM since Q2-2011. When including specific items, the operating
income amounted to $29 million in comparison to a loss of $6 million in
the same period of last year.
In the first quarter of 2012, these specific items impacted our
operating income and/or net earnings (before tax):
a $2 million unrealized gain on financial instruments (impact on
operating income and net earnings);
a $1 million gain on disposal and others (operating income and net
earnings);
a $2 million foreign exchange gain on long-term debt and financial
instruments (net earnings);
a $2 million after-tax loss included in discontinued operations (net
earnings).
For further details, see the two following tables on IFRS and non-IFRS
measures reconciliation included herewith.
Net earnings excluding specific items amounted to $4 million ($0.04 per
share) in the first quarter of��2012 compared to net earnings of $1
million ($0.01 per share) for the same period of last year. Including
specific items, net earnings amounted to $6 million ($0.06 per share)
compared to a loss of $8 million ($0.08 per share) for the same quarter
in 2011.
Results analysis for the three-month period ended March 31, 2012
(compared to the previous quarter)
In comparison to the previous quarter, sales decreased slightly mostly
due the impact of lower average selling prices caused by a less
favorable product mix and the appreciation of the Canadian dollar.
Despite lower sales, operating income and net earnings improved
primarily due to lower fibre costs that more than offset a decrease in
average selling prices and higher energy costs.
Net debt increased by $39 million to $1,524 million as a result of
capital investments and a build-up in working capital. Of this amount,
$173 million is non-recourse
Dividend on common shares and normal course issuer bid
The Board of Directors of Cascades declared a quarterly dividend of
$0.04 per share to be paid June 7, 2012 to shareholders of record at
the close of business on May 25, 2012. This dividend paid by Cascades
is an "eligible dividend" as per the Income Tax Act (Bill C-28,
Canada).
In the first quarter of 2012, Cascades purchased for cancellation
512,200 shares at an average price of $4.34 representing an aggregate
amount of approximately $2.2 million.
Supplemental information on non-IFRS measures
Operating income before depreciation and amortization, earnings before
interests, taxes, depreciation and amortization, operating income and
cash flow from operations are not measures of performance under IFRS.
The Corporation includes operating income before depreciation and
amortization, earnings before interests, taxes, depreciation and
amortization, operating income and cash flow from operations because
they are measures used by management to assess the operating and
financial performance of the Corporation's operating segments.
Additionally, the Corporation believes that these items provide
additional measures often used by investors to assess a company's
operating performance and its ability to meet debt service
requirements. However, operating income before depreciation and
amortization, earnings before interests, taxes, depreciation and
amortization, operating income and cash flow from operations do not
represent, and should not be used as a substitute for net earnings or
cash flows from operating activities as determined in accordance with
IFRS, and they are not necessarily an indication of whether cash flow
will be sufficient to fund our cash requirements. In addition, our
definition of operating income before depreciation and amortization,
earnings before interests, taxes, depreciation and amortization,
operating income and cash flow from operations may differ from those of
other companies. Cash flow from operations is defined as cash flow from
operating activities as determined in accordance with IFRS excluding
the change in working capital components.
Operating income before depreciation and amortization excluding specific
items, earnings before interests, taxes, depreciation and amortization
excluding specific items, operating income excluding specific items,
net earnings excluding specific items, net earnings per common share
excluding specific items and cash flow from operations excluding
specific items are non-IFRS measures. The Corporation believes that it
is useful for investors to be aware of specific items that have
adversely or positively affected its IFRS measures, and that the above
mentioned non-IFRS measures provide investors with a measure of
performance�� with which to compare its results between periods without
regard to these specific items. The Corporation's measures excluding
specific items have no standardized meaning prescribed by IFRS and are
not necessarily comparable to similar measures presented by other
companies and therefore should not be considered in isolation.
Specific items are defined to include charges for impairment of assets,
charges for facility or machine closures, debt restructuring charges,
gains or losses on sale of business unit, unrealized gains or losses on
derivative financial instruments that do not qualify for hedge
accounting, foreign exchange gains or losses on long-term debt and
other significant items of an unusual or non-recurring nature.
Net earnings (loss), which is a performance measure defined by IFRS is
reconciled below to operating income (loss), operating income excluding
specific items and operating income before depreciation excluding
specific items or earnings before interests, taxes, depreciation and
amortization excluding specific items:
�� | �� | �� | �� |
(in millions of Canadian dollars) (unaudited) | Q1/2012 | Q1/2011 | Q4/2011 |
�� | �� | �� | �� |
Net earnings (loss) | 6 | (8) | 5 |
Net loss (earnings) from discontinued operations | 2 | (6) | (1) |
Non-controlling interest | (1) | - | - |
Share of results of associates and joint ventures | (2) | (8) | (3) |
Provision for (recovery of) income taxes | 1 | (14) | (31) |
Foreign exchange loss (gain) on long-term debt and financial instruments | (2) | 5 | (9) |
Financing expense | 25 | 25 | 25 |
�� | �� | �� | �� |
Operating income (loss) | 29 | (6) | (14) |
Specific items : | �� | �� | �� |
Inventory adjustment resulting from business acquisition | - | - | 4 |
Loss (gain) on acquisitions, disposals and others | (1) | 1 | (38) |
Impairment charges | - | 1 | 44 |
Closure and restructuring costs | - | 3 | 3 |
Unrealized loss (gain) on financial instruments | (2) | 2 | 1 |
�� | (3) | 7 | 14 |
�� | �� | �� | �� |
Operating income - excluding specific items | 26 | 1 | - |
Depreciation and amortization | 46 | 36 | 51 |
Operating income before depreciation and amortization (OIBD or EBITDA) - excluding specific items | 72 | 37 | 51 |
The following table reconciles net earnings (loss) and net earnings
(loss) per share to net earnings (loss) excluding specific items and
net earnings (loss) per share excluding specific items:
�� | �� | �� | �� | ||||
(in millions of Canadian dollars, except amounts per share) (unaudited) | Net earnings (loss) | �� | Net earnings (loss)��per share 1 | ||||
�� | Q1/2012 | Q1/2011 | Q4/2011 | �� | Q1/2012 | Q1/2011 | Q4/2011 |
�� | �� | �� | �� | �� | �� | �� | �� |
As per IFRS | 6 | (8) | 5 | �� | $0.06 | $(0.08) | $0.05 |
Specific items : | �� | �� | �� | �� | �� | �� | �� |
Inventory adjustment resulting from business acquisition | - | - | 4 | �� | $ - | $ - | $0.04 |
Loss (gain) on acquisitions, disposals and others | (1) | 1 | (38) | �� | $(0.01) | $0.01 | $(0.40) |
Impairment charges | - | 1 | 44 | �� | $ - | $0.01 | $0.34 |
Closure and restructuring costs | - | 3 | 3 | �� | $ - | $0.02 | $0.02 |
Unrealized loss (gain) on financial instruments | (2) | 2 | 1 | �� | $(0.01) | $0.02 | $0.01 |
Foreign exchange loss (gain) on long-term debt and financial instruments | (2) | 5 | (9) | �� | $(0.02) | $0.04 | $(0.08) |
Share of results of associates, joint ventures and non-controlling interest | - | - | (2) | �� | $ - | $ - | $(0.02) |
Included in discontinued operations, net of tax | 2 | (1) | (1) | �� | $0.02 | $(0.01) | $ - |
Tax effect on specific items and other tax adjustments | 1 | (2) | (11) | �� | �� | �� | �� |
�� | (2) | 9 | (9) | �� | $(0.02) | $0.09 | $(0.09) |
Excluding specific items | 4 | 1 | (4) | �� | $0.04 | $0.01 | $(0.04) |
��Note 1 - specific amounts per share are calculated on an after-tax
basis.
The following table reconciles cash flow provided by (used from)
operating activities to cash flow (adjusted) from operations excluding
specific items:
�� | �� | ||
�� | Cash flow from operations | ||
(in millions of Canadian dollars) (unaudited) | Q1/2012 | Q1/2011 | Q4/2011 |
�� | �� | �� | �� |
Cash flow provided by (used from) operating activities | 24 | (12) | 102 |
Changes in non-cash working capital components | 24 | 27 | (67) |
Cash flow (adjusted) from operations | 48 | 15 | 35 |
Specific items, net of current income tax | �� | �� | �� |
Closure and restructuring costs | - | - | 5 |
Excluding specific items | 48 | 15 | 40 |
CONSOLIDATED BALANCE SHEETS
(in millions of Canadian dollars) (unaudited) | March 31, 2012 | December 31, 2011 |
Assets | �� | �� |
Current assets | �� | �� |
Cash and cash equivalents | 11 | 12 |
Cash reserved for business aquisition1 | 14 | - |
Accounts receivable | 553 | 535 |
Current income tax assets | 25 | 24 |
Inventories | 530 | 516 |
Financial assets | 30 | 6 |
Assets held for sale | 11 | 12 |
�� | 1,174 | 1,105 |
Long-term assets | �� | �� |
Investments in associates and joint ventures | 243 | 219 |
Property, plant and equipment | 1,689 | 1,703 |
Intangible assets | 185 | 185 |
Financial assets | 12 | 25 |
Other assets | 45 | 44 |
Deferred income tax assets | 122 | 119 |
Goodwill and others | 329 | 328 |
�� | 3,799 | 3,728 |
Liabilities and Equity | �� | �� |
Current liabilities | �� | �� |
Bank loans and advances | 97 | 90 |
Trade and other payables | 545 | 539 |
Current income tax liabilities | 3 | 2 |
Current portion of provisions for contingencies and charges | 2 | 5 |
Current portion of financial liabilities and other liabilities | 83 | 20 |
Current portion of long-term debt | 56 | 49 |
�� | 786 | 705 |
Long-term liabilities | �� | �� |
Long-term debt | 1,396 | 1,358 |
Provisions for contingencies and charges | 35 | 33 |
Financial liabilities | 61 | 111 |
Other liabilities | 258 | 249 |
Deferred income tax liabilities | 105 | 107 |
�� | 2,641 | 2,563 |
Equity attributable to Shareholders | �� | �� |
Capital stock | 483 | 486 |
Contributed surplus | 15 | 14 |
Retained earnings | 608 | 615 |
Accumulated other comprehensive loss | (82) | (86) |
�� | 1,024 | 1,029 |
Non-controlling interest | 134 | 136 |
Total equity | 1,158 | 1,165 |
�� | 3,799 | 3,728 |
1�� As of March 31, 2012, $14 million of cash is reserved for the
acquisition of Bird Packaging Limited closed on April 1, 2012.
CONSOLIDATED STATEMENT OF EARNINGS
For the 3-month periods ended March 31, (in millions of Canadian dollars, except per share amounts and number of shares) (unaudited) | 2012 | 2011 | |
Sales | 891 | 774 | |
Cost of sales and expenses | �� | �� | |
Cost of sales (including depreciation and amortization of $46 million; 2011-$36��million) | 770 | 697 | |
Selling and administrative expenses | 94 | 77 | |
Loss (gain) on disposals and others | (1) | 1 | |
Impairment charges and restructuring costs | - | 4 | |
Foreign exchange loss | 1 | - | |
Loss (gain) on derivative financial instruments | (2) | 1 | |
�� | 862 | 780 | |
Operating income (loss) | 29 | (6) | |
Financing expense | 25 | 25 | |
Foreign exchange loss (gain) on long-term debt and financial instruments | (2) | 5 | |
Profit (loss) before income taxes | 6 | (36) | |
Provision for (recovery of) income taxes | 1 | (14) | |
Share of results of associates and joint ventures | (2) | (8) | |
Net earnings (loss) from continuing operations including non-controlling interest for the period | 7 | (14) | |
Net earnings (loss) from discontinued operations for the period | (2) | 6 | |
Net earnings (loss) including non-controlling interest for the period | 5 | (8) | |
Net loss attributable to non-controlling interest | (1) | - | |
Net earnings (loss) attributable to Shareholders for the period | 6 | (8) | |
Net earnings (loss) from continuing operations per common share | �� | �� | |
�� | Basic | $0.08 | ($0.15) |
�� | Diluted | $0.08 | ($0.15) |
Net earnings (loss) per common share | �� | �� | |
�� | Basic | $0.06 | ($0.08) |
�� | Diluted | $0.06 | ($0.08) |
Weighted average basic number of common shares outstanding | 94,497,766 | 96,606,421 | |
�� | �� | �� | |
Net earnings (loss) attributable to Shareholders: | �� | �� | |
�� | Continuing operations | 8 | (14) |
�� | Discontinued operations | (2) | 6 |
Net earnings (loss) | 6 | (8) |
CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS
For the 3-month periods ended March 31, (in millions of Canadian dollars) (unaudited) | 2012 | 2011 | ||
Net earnings (loss) including non-controlling interest for the period | 5 | (8) | ||
Other comprehensive income (loss) | �� | �� | ||
�� | Translation adjustments | �� | �� | |
�� | �� | Change in foreign currency translation of foreign subsidiaries | (5) | (9) |
�� | �� | Change in foreign currency translation related to net investment hedging activities | 8 | 15 |
�� | �� | Income taxes | (1) | (2) |
�� | Cash flow hedges | �� | �� | |
�� | �� | Change in fair value of foreign exchange forward contracts | 5 | (1) |
�� | �� | Change in fair value of interest rate swaps | 3 | 1 |
�� | �� | Change in fair value of commodity derivative financial instruments | (2) | 4 |
�� | �� | Income taxes | (3) | (1) |
�� | Actuarial loss on post-employment benefit obligations | (14) | - | |
�� | �� | Income taxes | 4 | - |
�� | Available-for-sale financial assets | (1) | - | |
Other comprehensive income (loss) | (6) | 7 | ||
Comprehensive loss including non-controlling interest for the period | (1) | (1) | ||
Comprehensive income (loss) attributable to non-controlling interest for the period | (1) | - | ||
Comprehensive income (loss) attributable to Shareholders for the period | - | (1) | ||
�� | �� | �� | ||
Comprehensive income (loss) attributable to Shareholders: | �� | �� | ||
�� | Continuing operations | 2 | (7) | |
�� | Discontinued operations | (2) | 6 | |
Comprehensive income (loss) | - | (1) |
CONSOLIDATED STATEMENTS OF EQUITY
�� | �� | For the 3-month period ended March 31, 2012 | ||||||
(in millions of Canadian dollars) (unaudited) | Capital stock | Contributed surplus | Retained earnings | Accumulated other comprehensive loss | Total equity attributable to Shareholders | Non-controlling interest | Total equity | |
Balance���Beginning of period | 486 | 14 | 615 | (86) | 1,029 | 136 | 1,165 | |
Comprehensive income (loss) | �� | �� | �� | �� | �� | �� | �� | |
�� | Net earnings (loss) | - | - | 6 | - | 6 | (1) | 5 |
�� | Other comprehensive income (loss) | - | - | (10) | 4 | (6) | - | (6) |
�� | - | - | (4) | 4 | - | (1) | (1) | |
Dividends | - | - | (4) | - | (4) | - | (4) | |
Redemption of common shares | (3) | 1 | - | - | (2) | - | (2) | |
Acquisition of non-controlling interest | - | - | 1 | - | 1 | (1) | - | |
Balance���End of period | 483 | 15 | 608 | (82) | 1,024 | 134 | 1,158 | |
�� | �� | �� | �� | �� | �� | �� | �� | |
�� | For the 3-month period ended March 31, 2011 | |||||||
(in millions of Canadian dollars) (unaudited) | Capital stock | Contributed surplus | Retained earnings | Accumulated other comprehensive loss | Total equity attributable to Shareholders | Non-controlling interest | Total equity | |
Balance���Beginning of period | 496 | 14 | 576 | (37) | 1,049 | 23 | 1,072 | |
Comprehensive income (loss) | �� | �� | �� | �� | �� | �� | �� | |
�� | Net loss | - | - | (8) | - | (8) | - | (8) |
�� | Other comprehensive income | - | - | - | 7 | 7 | - | 7 |
�� | - | - | (8) | 7 | (1) | - | (1) | |
Dividends | - | - | (4) | - | (4) | - | (4) | |
Stock options | - | (1) | - | - | (1) | - | (1) | |
Redemption of common shares | (1) | - | - | - | (1) | - | (1) | |
Balance���End of period | 495 | 13 | 564 | (30) | 1,042 | 23 | 1,065 |
CONSOLIDATED STATEMENTS OF CASH FLOWS
For the 3-month periods ended March 31, (in millions of Canadian dollars) (unaudited) | 2012 | 2011 | |
Operating activities from continuing operations | �� | �� | |
Net earnings (loss) attributable to Shareholders for the period | 6 | (8) | |
Net loss (earnings) from discontinued operations for the period | 2 | (6) | |
Net earnings (loss) from continuing operations | 8 | (14) | |
Adjustments for | �� | �� | |
�� | Financing expense | 25 | 25 |
�� | Depreciation and amortization | 46 | 36 |
�� | Loss (gain) on disposals and others | (1) | 1 |
�� | Impairment charges and restructuring costs | - | 4 |
�� | Loss (gain) on derivative financial instruments | (2) | 2 |
�� | Foreign exchange loss (gain) on long-term debt and financial instruments | (2) | 5 |
�� | Provision for (recovery of) income taxes | 1 | (14) |
�� | Share of results of associates and joint ventures | (2) | (8) |
�� | Non-controlling interest | (1) | - |
�� | Net financing expense paid | (15) | (17) |
�� | Income taxes paid | (4) | (3) |
�� | Others | (5) | (2) |
�� | 48 | 15 | |
Changes in non-cash working capital components | (24) | (27) | |
�� | 24 | (12) | |
Investing activities from continuing operations | �� | �� | |
Purchase of investments in associates and joint ventures | (19) | (2) | |
Purchase of property, plant and equipment | (48) | (35) | |
Proceeds on disposal of property, plant and equipment | 5 | - | |
Cash reserved for business acquisition | (14) | - | |
Change in other assets | (4) | (8) | |
�� | (80) | (45) | |
Financing activities from continuing operations | �� | �� | |
Bank loans and advances | 6 | 4 | |
Change in revolving credit facilities | 81 | 51 | |
Purchase of senior notes | (3) | - | |
Payments of other long-term debt | (23) | (2) | |
Redemption of common shares | (2) | (1) | |
Dividends paid to Corporation's Shareholders | (4) | (4) | |
�� | 55 | 48 | |
Change in cash and cash equivalents during the period from continuing operations | (1) | (9) | |
Change in cash and cash equivalents from discontinued operations, including proceeds on disposal during the period | - | 13 | |
Net change in cash and cash equivalents during the period | (1) | 4 | |
Cash and cash equivalents���Beginning of period | 12 | 6 | |
Cash and cash equivalents���End of period | 11 | 10 |
SEGMENTED INFORMATION
In 2012, the Corporation changed the structure of its internal
organization in a manner that caused the composition of its reportable
segment to change. As a result, the Corporation modified its segmented
information disclosure for the current period and restated prior
periods. Containerboard and Boxboard North America manufacturing and
converting are now presented within one segment. Boxboard European
activities are reported as a separate segment.
The Corporation's operations are managed in four segments:
Containerboard, Boxboard Europe, Specialty Products (which consists of
the packaging products of the Corporation) and Tissue Papers.
�� | SALES | ||
For the 3-month periods ended March 31, (in millions of Canadian dollars) (unaudited) | 2012 | 2011 | |
Packaging Products | �� | �� | |
�� | Containerboard | 284 | 344 |
�� | Boxboard Europe | 204 | 62 |
�� | Specialty Products | 202 | 202 |
�� | Intersegment sales | (18) | (27) |
�� | 672 | 581 | |
Tissue Papers | 229 | 199 | |
Intersegment sales and others | (10) | (6) | |
Total | 891 | 774 | |
�� | �� | �� | |
�� | OPERATING INCOME (LOSS) BEFORE DEPRECIATION AND AMORTIZATION | ||
For the 3-month periods ended March 31, (in millions of Canadian dollars) (unaudited) | 2012 | 2011 | |
Packaging Products | �� | �� | |
�� | Containerboard | 24 | 13 |
�� | Boxboard Europe | 13 | 4 |
�� | Specialty Products | 11 | 7 |
�� | 48 | 24 | |
Tissue Papers | 33 | 10 | |
Corporate | (6) | (4) | |
Operating income before depreciation and amortization | 75 | 30 | |
Depreciation and amortization | (46) | (36) | |
Financing expense | (25) | (25) | |
Foreign exchange (loss) gain on long-term debt and financial instruments | 2 | (5) | |
Profit (loss) before income taxes | 6 | (36) | |
�� | �� | �� | |
�� | PURCHASE OF PROPERTY, PLANT AND EQUIPMENT | ||
For the 3-month periods ended March 31, (in millions of Canadian dollars) (unaudited) | 2012 | 2011 | |
Packaging Products | �� | �� | |
�� | Containerboard | 14 | 8 |
�� | Boxboard Europe | 5 | 1 |
�� | Specialty Products | 3 | 6 |
�� | 22 | 15 | |
Tissue Papers | 8 | 6 | |
Corporate | 3 | 2 | |
Total purchases | 33 | 23 | |
Proceeds on disposal of property, plant and equipment | (5) | - | |
�� | 28 | 23 | |
Purchase of property, plant and equipment included in trade and other payables | �� | �� | |
�� | Beginning of period | 25 | 18 |
�� | End of period | (10) | (6) |
Purchases of property, plant and equipment net of proceeds on disposals | 43 | 35 |
Founded in 1964, Cascades produces, converts and markets packaging and
tissue products that are composed mainly of recycled fibres. The
Corporation employs more than 12,000 employees, who work in more than
100 units located in North America and Europe. With its management
philosophy, half a century of experience in recycling, and continuous
efforts in research and development as driving forces, Cascades
continues to serve its clients with innovative products. Cascades'
shares trade on the Toronto Stock Exchange, under the ticker symbol
CAS.
Certain statements in this release, including statements regarding
future results and performance, are forward-looking statements (as such
term is defined under the Private Securities Litigation Reform Act of
1995) based on current expectations. The accuracy of such statements is
subject to a number of risks, uncertainties and assumptions that may
cause actual results to differ materially from those projected,
including, but not limited to, the effect of general economic
conditions, decreases in demand for the Corporation's products,
increases in raw material costs, fluctuations in selling prices and
adverse changes in general market and industry conditions and other
factors listed in the Corporation's Securities and Exchange Commission
filings.
��
��
��
For further information:
Media
Hubert Bolduc
Vice-President, Communications and Public Affairs
514 912-3790
Investors
Riko Gaudreault
Director, Investor relations
514��282-2697
Source:
Allan Hogg
Vice-President and Chief Financial Officer
No comments:
Post a Comment